Sep 12, 2023 / 03:30PM GMT
Tejas Rajeev Savant - Morgan Stanley, Research Division - Equity Analyst
All right. Good morning, everyone. My name is Tejas Savant, and I'm the life science tools and diagnostics analyst here at Morgan Stanley. Before we begin, for important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. If you have any questions, do reach out to your Morgan Stanley sales rep.
So it's my great pleasure this morning to have CEO and Chairman of IQVIA, Ari Bousbib; and Head of Investor Relations, Nick Childs, on stage here with me. Now for those of you who've been following the space for a while, Ari is a bit of a rare commodity at sell-side sort of conferences. In my many years at JPMorgan, he's also one of those health care CEOs that's allergic to the Westin St. Francis. So it is truly a privilege to share the stage with you.
Questions and Answers:
Tejas Rajeev Savant - Morgan Stanley, Research Division - Equity AnalystMaybe to kick things off, Ari, can you just outline for us what you view as
Trustpilot
